Partner Fund Management »

Definium Therape shares owned by Partner Fund Management

Quarter-by-quarter ownership of Definium Therape (DFTX) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Definium Therape

Tip: Access up to 7 years of quarterly data

All positions including Definium Therape held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Definium Therape by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.9M 205k 18.90

More positions owned by Partner Fund Management

Tenet Healthcare Corp Com New (THC)
United Therapeutics Corporation (UTHR)
Eli Lilly & Co. (LLY)
Spdr Series Trust State Street Spd Put Option (XBI)
Penumbra (PEN)
Axsome Therapeutics (AXSM)
Ascendis Pharma A/s Sponsored Adr
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Centessa Pharmaceuticals Sponsored Ads
Inhibrx Biosciences (INBX)
Edwards Lifesciences (EW)
Bridgebio Pharma (BBIO)

View all positions for Partner Fund Management

Top funds holding Definium Therape

BlackRock
Driehaus Capital Management
venBio Select Advisor
Henderson Group
Deep Track Capital
Geode Capital Management
State Street Corporation
Octagon Capital Advisors
Commodore Capital
FMR
Trails Edge Capital Partners
Goldman Sachs Group
Arrowpoint Asset Management
Citadel Advisors
Wellington Management Company

View all funds holding Definium Therape